VSBC OTC
VitaSpring Biomedical Co. Ltd.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -98.9%
1Y: -98.9%
3Y: -99.9%
5Y: -99.9%
$0.01
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$10K
+0.0% ▲
Operating Income
-$385K
+0.0% ▲
Net Income
-$415K
+0.0% ▲
EPS (Diluted)
$-0.00
+0.0% ▲
EBITDA
-$375K
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $15K | $248K | $6M | $0 | $0 |
| YoY Growth | -11.9% | +1539.4% | +2161.6% | -100.0% | +0.0% |
| Cost of Revenue | $13K | $136K | $4M | $219K | $10K |
| Gross Profit | $2K | $112K | $2M | -$219K | -$10K |
| Gross Margin | 11.2% | 45.2% | 36.8% | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $21K | $536K | $569K | $626K | $385K |
| Operating Expenses | $21K | $537K | $585K | $4M | $375K |
| Operating Income | -$19K | -$425K | $1M | -$4M | -$385K |
| Operating Margin | -128.7% | -171.4% | 26.4% | — | — |
| Interest Expense | $0 | $670 | $2K | $0 | $0 |
| Income Before Tax | $7K | -$425K | $1M | -$4M | -$385K |
| Tax Expense | $0 | $0 | $217K | -$5K | $30K |
| Net Income | $7K | -$425K | $1M | -$4M | -$415K |
| Net Margin | 45.7% | -171.4% | 22.5% | — | — |
| EPS (Diluted) | $0.00 | $-0.00 | $0.01 | $-0.02 | $-0.00 |
| EBITDA | -$19K | -$424K | $1M | -$4M | -$375K |
| Shares Outstanding | 55M | 91M | 206M | 207M | 207M |